Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2026)

Organogenesis Holdings (ORGO) recorded quarterly Other Non-Current Assets of $16.1 million in Q1 2026, up 75.26% quarter-over-quarter from $9.2 million in Q4 2025, and up 176.47% on a YoY basis from $5.8 million in Q1 2025.

Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Organogenesis Holdings' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $16.1 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 176.47% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (up 176.47% YoY), while the FY2025 annual figure was $9.2 million, up 83.88% from the prior year.
  • Other Non-Current Assets was $16.1 million for Q1 2026 at Organogenesis Holdings, up from $9.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $16.1 million in Q1 2026 to a low of $1.3 million in Q3 2023.
  • Historically, Other Non-Current Assets has averaged $5.5 million across 5 years, with a median of $5.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets dropped 16.87% in 2023, then soared 358.58% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.5 million in 2022, then soared by 294.08% to $6.0 million in 2023, then declined by 16.44% to $5.0 million in 2024, then soared by 83.88% to $9.2 million in 2025, then jumped by 75.26% to $16.1 million in 2026.
  • The last three Other Non-Current Assets figures came in at $16.1 million (Q1 2026), $9.2 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Organogenesis Holdings 317.58 Mn 225.48 Mn 11.46 Mn 16.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.13 Mn
Dec 31, 2025 9.20 Mn
Sep 30, 2025 14.41 Mn
Jun 30, 2025 8.73 Mn
Mar 31, 2025 5.83 Mn
Dec 31, 2024 5.01 Mn
Sep 30, 2024 5.01 Mn
Jun 30, 2024 5.85 Mn
Mar 31, 2024 6.71 Mn
Dec 31, 2023 5.99 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.39 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 1.59 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 1.47 Mn
Dec 31, 2021 1.54 Mn
Sep 30, 2021 1.61 Mn
Jun 30, 2021 605,000.00